PeopleBio, Inc.

A304840

KR7304840002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
3,485 ^KRW	+2.80%		+8.74%	+13.33%

2023	PeopleBio, Inc. announced that it has received KRW 5.399992647 billion in funding	CI
2023	Peoplebio to Raise 5.4 Billion Won From Shares Issuance	MT

PeopleBio, Inc.(KOSDAQ:A304840) added to S&P Global BMI Index

March 22, 2021 at 09:30 am IST

Latest news about PeopleBio, Inc.

PeopleBio, Inc. announced that it has received KRW 5.399992647 billion in funding	29/23/29	CI
Peoplebio to Raise 5.4 Billion Won From Shares Issuance	22/23/22	MT
PeopleBio, Inc. announced that it expects to receive KRW 5.399992647 billion in funding	21/23/21	CI
PeopleBio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	20/23/20	CI
PeopleBio, Inc. announced that it has received KRW 6 billion in funding from UTC Investment Co., Ltd.	29/21/29	CI
PeopleBio, Inc. cancelled the transaction announced on July 1, 2021	26/21/26	CI
PeopleBio, Inc. announced that it expects to receive KRW 19.999988224 billion in funding from UTC Investment Co., Ltd.	01/21/01	CI
PeopleBio, Inc. announced that it expects to receive KRW 37.999966504 billion in funding from Hanyang Securities Co. Ltd., Aju IB Investment Co., Ltd., NH Investment & Securities Co., Ltd., Investment Arm, Nau IB Capital, Investment Arm, Kiwoom Securities Co., Ltd., iMarketKorea Inc. and other investors	21/21/21	CI
PeopleBio, Inc.(KOSDAQ:A304840) added to S&P Global BMI Index	22/21/22	CI
PeopleBio, Inc. has completed an IPO in the amount of KRW 10 billion.	14/20/14	CI
PeopleBio, Inc. has filed an IPO.	14/20/14	CI

PeopleBio Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical supplies. The Company's main products include oligomerized beta-amyloid (OAÎ²) test systems, and others. The Companyâs multimer detection system (MDS) is sandwich assay using capturing antibodies and epitope-overlapping detection antibodies for the detection of only oligomers or multimers from monomers in protein-misfolding diseases. The Company sells its products in domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
PEOPLEBIO, INC.	+13.33%	5.32Cr
BIOMÉRIEUX	-11.23%	1.12TCr
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-13.76%	729.18Cr
LANTHEUS HOLDINGS, INC.	+29.50%	556.51Cr
AUTOBIO DIAGNOSTICS CO., LTD.	-19.19%	368.03Cr
ANDON HEALTH CO., LTD.	+7.62%	258.29Cr
10X GENOMICS, INC.	-65.24%	232.83Cr
VITROLIFE AB	-10.63%	222.66Cr
MYRIAD GENETICS, INC.	+27.80%	221.38Cr
GUANGZHOU WONDFO BIOTECH CO.,LTD	-19.12%	157.21Cr